These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 206853)

  • 21. Effect of pimozide on the cytology of the eel pituitary. II. MSH-secreting cells.
    Olivereau M
    Cell Tissue Res; 1978 May; 189(2):231-9. PubMed ID: 657240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MSH activity in pituitary glands of rats treated with tranquilizing drugs.
    Kastin AJ; Schally AV
    Endocrinology; 1966 Nov; 79(5):1018-20. PubMed ID: 5951274
    [No Abstract]   [Full Text] [Related]  

  • 23. Kappa-opioid-receptor-mediated regulation of alpha-melanocyte-stimulating hormone secretion and tuberohypophyseal dopaminergic neuronal activity.
    Manzanares J; Lookingland KJ; Moore KE
    Neuroendocrinology; 1990 Aug; 52(2):200-5. PubMed ID: 2177159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of the pituitary in modulating the effect of the dopaminergic and serotoninergic systems on the immune response].
    Al'perina EL; Idova GV; Devoĭno LV
    Fiziol Zh SSSR Im I M Sechenova; 1985 Nov; 71(11):1428-32. PubMed ID: 3002871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of alpha-melanocyte-stimulating hormone secretion from the pars intermedia of domestic cats.
    Kemppainen RJ; Peterson ME
    Am J Vet Res; 1999 Feb; 60(2):245-9. PubMed ID: 10048560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation by dopamine antagonists of DNA synthesis in the pituitary gland of the male rat.
    Jacobi JM; Lloyd HM
    Neuroendocrinology; 1981 Aug; 33(2):97-100. PubMed ID: 7266775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Responsiveness of intermediate lobe cells to neural mediators in culture.
    Fazekas I; Medzihradszky-Schweiger H; Rappay G; Acs Z; Fekete M; Gyévai A
    Exp Clin Endocrinol; 1984 Dec; 84(3):338-45. PubMed ID: 6098487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of receptors for dopamine in the pars intermedia of the amphibian Xenopus laevis.
    Verburg-Van Kemenade BM; Tonon MC; Jenks BG; Vaudry H
    Neuroendocrinology; 1986; 44(4):446-56. PubMed ID: 3822075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre- and postnatal developmental changes in hypothalamic and pituitary content of alpha-melanocyte-stimulating hormone and somatostatin in the rat.
    Khorram O; McCann SM
    Biol Neonate; 1984; 46(2):80-8. PubMed ID: 6146354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of gamma-melanocyte-stimulating hormone secretion is accompanied by salt-sensitive hypertension in the rat.
    Mayan H; Ni XP; Almog S; Humphreys MH
    Hypertension; 2003 Nov; 42(5):962-7. PubMed ID: 14568996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of the interaction between pro-leu-gly-NH2 and catecholaminergic drugs on MSH release from rat pituitaries incubated in vitro.
    Vivas A; Celis ME
    Neuroendocrinology; 1982; 35(3):150-4. PubMed ID: 6127639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of pimozide on the ultrastructure of the pars intermedia in the rat.
    Santolaya RC; Ciocca D
    Cell Tissue Res; 1981; 217(2):397-403. PubMed ID: 7237535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo effect of dopamine antagonists on melanocyte-stimulating hormone cells of the goldfish (Carassius auratus L.) pituitary.
    Olivereau M; Olivereau JM; Lambert JF
    Gen Comp Endocrinol; 1987 Oct; 68(1):12-8. PubMed ID: 3666418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of hypothalamic lesions on the melanocyte stimulating hormone content and histology of the pars intermedia of the rat pituitary gland.
    Howe A; Thody AJ
    J Physiol; 1969 Mar; 201(1):25P-26P. PubMed ID: 5773561
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanism of action of dopamine on the in vitro release of gonadotropin-releasing hormone.
    Jarjour LT; Handelsman DJ; Raum WJ; Swerdloff RS
    Endocrinology; 1986 Oct; 119(4):1726-32. PubMed ID: 3019641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of suckling on the hypothalamic and pituitary secretion of immunoreactive alpha-melanocyte stimulating hormone.
    Khorram O; Bedran deCastro JC; McCann SM
    Brain Res; 1986 Nov; 398(2):361-5. PubMed ID: 3801909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Norepinephrine content in the paraventicular nucleus of the hypothalamus as a function of photoperiod and dopaminergic tone.
    Woods KA; Buechi KA; Illig AM; Badura LL
    Endocrine; 1998 Feb; 8(1):79-83. PubMed ID: 9666349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MSH and MIF-I in animal models of tardive dyskinesia.
    Davis KL; Kastin AJ; Beilstein BA; Vento AL
    Pharmacol Biochem Behav; 1980 Jul; 13(1):37-40. PubMed ID: 6105677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological manipulation of anterior pituitary dopamine content in the male rat: relationship to serum prolactin concentration and lysosomal enzyme activity.
    Demarest KT; Riegle GD; Moore KE
    Endocrinology; 1984 Aug; 115(2):493-500. PubMed ID: 6745164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hypothalamic melanocortin system stimulates the hypothalamo-pituitary-adrenal axis in vitro and in vivo in male rats.
    Dhillo WS; Small CJ; Seal LJ; Kim MS; Stanley SA; Murphy KG; Ghatei MA; Bloom SR
    Neuroendocrinology; 2002 Apr; 75(4):209-16. PubMed ID: 11979051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.